Drug class · Endocrine & metabolism
DPP-4 inhibitors
Oral drugs that inhibit the dipeptidyl peptidase-4 enzyme, alone or in fixed combinations.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| alogliptin and metformin hydrochloride | Alogliptin benzoate 12.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Padagis Israel Pharmaceuticals Ltd | 45802-169 |
| alogliptin and metformin hydrochloride | Alogliptin benzoate 12.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Padagis Israel Pharmaceuticals Ltd | 45802-211 |